124 related articles for article (PubMed ID: 37939606)
1. Added value of clinical decision rules for the management of enhancing breast MRI lesions: A systematic comparison of the Kaiser score and the Göttingen score.
Dietzel M; Bernathova M; Clauser P; Kapetas P; Uder M; Baltzer PAT
Eur J Radiol; 2023 Dec; 169():111185. PubMed ID: 37939606
[TBL] [Abstract][Full Text] [Related]
2. Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI.
Wengert GJ; Pipan F; Almohanna J; Bickel H; Polanec S; Kapetas P; Clauser P; Pinker K; Helbich TH; Baltzer PAT
Eur Radiol; 2020 Mar; 30(3):1451-1459. PubMed ID: 31797077
[TBL] [Abstract][Full Text] [Related]
3. The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams.
Milos RI; Pipan F; Kalovidouri A; Clauser P; Kapetas P; Bernathova M; Helbich TH; Baltzer PAT
Eur Radiol; 2020 Nov; 30(11):6052-6061. PubMed ID: 32504098
[TBL] [Abstract][Full Text] [Related]
4. Using the Kaiser Score as a clinical decision rule for breast lesion classification: Does computer-assisted curve type analysis improve diagnosis?
Pötsch N; Vatteroni G; Clauser P; Rainer E; Kapetas P; Milos R; Helbich TH; Baltzer P
Eur J Radiol; 2024 Jan; 170():111271. PubMed ID: 38185026
[TBL] [Abstract][Full Text] [Related]
5. Value of contrast-enhanced mammography combined with the Kaiser score for clinical decision-making regarding tomosynthesis BI-RADS 4A lesions.
Rong X; Kang Y; Xue J; Han P; Li Z; Yang G; Shi G
Eur Radiol; 2022 Nov; 32(11):7439-7447. PubMed ID: 35639141
[TBL] [Abstract][Full Text] [Related]
6. Breast MRI: does a clinical decision algorithm outweigh reader experience?
Pötsch N; Korajac A; Stelzer P; Kapetas P; Milos RI; Dietzel M; Helbich TH; Clauser P; Baltzer PAT
Eur Radiol; 2022 Oct; 32(10):6557-6564. PubMed ID: 35852572
[TBL] [Abstract][Full Text] [Related]
7. A simple classification system (the Tree flowchart) for breast MRI can reduce the number of unnecessary biopsies in MRI-only lesions.
Woitek R; Spick C; Schernthaner M; Rudas M; Kapetas P; Bernathova M; Furtner J; Pinker K; Helbich TH; Baltzer PAT
Eur Radiol; 2017 Sep; 27(9):3799-3809. PubMed ID: 28275900
[TBL] [Abstract][Full Text] [Related]
8. A Multicentric Comparison of Apparent Diffusion Coefficient Mapping and the Kaiser Score in the Assessment of Breast Lesions.
Dietzel M; Krug B; Clauser P; Burke C; Hellmich M; Maintz D; Uder M; Bickel H; Helbich T; Baltzer PAT
Invest Radiol; 2021 May; 56(5):274-282. PubMed ID: 33122603
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of the Kaiser score in the evaluation of breast lesions on contrast-enhanced mammography.
Kang Y; Li Z; Yang G; Xue J; Zhang L; Rong X
Eur J Radiol; 2022 Nov; 156():110524. PubMed ID: 36126352
[TBL] [Abstract][Full Text] [Related]
10. The added value of apparent diffusion coefficient and microcalcifications to the Kaiser score in the evaluation of BI-RADS 4 lesions.
Pan J; Huang X; Yang S; Ouyang F; Ouyang L; Wang L; Chen M; Zhou L; Du Y; Chen X; Deng L; Hu Q; Guo B
Eur J Radiol; 2023 Aug; 165():110920. PubMed ID: 37320881
[TBL] [Abstract][Full Text] [Related]
11. Can DWI provide additional value to Kaiser score in evaluation of breast lesions.
An Y; Mao G; Ao W; Mao F; Zhang H; Cheng Y; Yang G
Eur Radiol; 2022 Sep; 32(9):5964-5973. PubMed ID: 35357535
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
13. Evidence-Based and Structured Diagnosis in Breast MRI using the Kaiser Score.
Baltzer PAT; Krug KB; Dietzel M
Rofo; 2022 Nov; 194(11):1216-1228. PubMed ID: 35613905
[TBL] [Abstract][Full Text] [Related]
14. Proposed Adjustments to PI-RADS Version 2 Decision Rules: Impact on Prostate Cancer Detection.
Rosenkrantz AB; Babb JS; Taneja SS; Ream JM
Radiology; 2017 Apr; 283(1):119-129. PubMed ID: 27783538
[TBL] [Abstract][Full Text] [Related]
15. Motion artifacts, lesion type, and parenchymal enhancement in breast MRI: what does really influence diagnostic accuracy?
Clauser P; Dietzel M; Weber M; Kaiser CG; Baltzer PA
Acta Radiol; 2019 Jan; 60(1):19-27. PubMed ID: 29667880
[TBL] [Abstract][Full Text] [Related]
16. Application of the Kaiser score by MRI in patients with breast lesions by ultrasound and mammography.
Wang Q; Fu F; Chen Y; Yang D; Zhang J; Yu H; Su L
Diagn Interv Radiol; 2022 Jul; 28(4):322-328. PubMed ID: 35950276
[TBL] [Abstract][Full Text] [Related]
17. Improved Differential Diagnosis Based on BI-RADS Descriptors and Apparent Diffusion Coefficient for Breast Lesions: A Multiparametric MRI Analysis as Compared to Kaiser Score.
Meng L; Zhao X; Guo J; Lu L; Cheng M; Xing Q; Shang H; Zhang B; Chen Y; Zhang P; Zhang X
Acad Radiol; 2023 Sep; 30 Suppl 2():S93-S103. PubMed ID: 37236897
[TBL] [Abstract][Full Text] [Related]
18. False-positive incidental lesions detected on contrast-enhanced breast MRI: clinical and imaging features.
Alikhassi A; Li X; Au F; Kulkarni S; Ghai S; Allison G; Freitas V
Breast Cancer Res Treat; 2023 Apr; 198(2):321-334. PubMed ID: 36740611
[TBL] [Abstract][Full Text] [Related]
19. Correct determination of the enhancement curve is critical to ensure accurate diagnosis using the Kaiser score as a clinical decision rule for breast MRI.
Grippo C; Jagmohan P; Helbich TH; Kapetas P; Clauser P; Baltzer PAT
Eur J Radiol; 2021 May; 138():109630. PubMed ID: 33744507
[TBL] [Abstract][Full Text] [Related]
20. Assessment of breast lesions by the Kaiser score for differential diagnosis on MRI: the added value of ADC and machine learning modeling.
Chen ZW; Zhao YF; Liu HR; Zhou JJ; Miao HW; Ye SX; He Y; Liu XM; Su MY; Wang MH
Eur Radiol; 2022 Oct; 32(10):6608-6618. PubMed ID: 35726099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
